Gujarat-based Supreet Chemicals Limited has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), marking a key step toward its proposed Initial Public Offering (IPO). The Supreet Chemicals IPO aims to raise funds aggregating up to ₹499 crore.
Supreet Chemicals IPO Details and Fund Utilization
The Supreet Chemicals IPO will comprise a fresh issue of equity shares worth ₹499 crore. As per the DRHP, the net proceeds are planned for:
- Capital expenditure of approximately ₹310 crore for Manufacturing Facility 4.
- Repayment or prepayment of borrowings estimated at ₹65 crore.
- General corporate purposes.
Also Read: Godrej Chemicals Business to Invest ₹750 Crore in Capacity Expansion
Business Operations and Industry Expertise
Supreet Chemicals is among the few specialty chemical intermediates manufacturers with expertise in handling complex chemistries, including more than 15 different reaction types and up to 15 multi-step unit processes.
Its product portfolio includes intermediates such as MCA, Sulphonamides, and NAPSA, primarily based on Aromatic Amines, Sulphonamides, and Amino Phenols.
The company’s products cater to a wide range of industries, including pharmaceuticals, textiles, performance chemicals, agrochemicals, and personal care.
Also Read: Smart Nano-Materials Enable Ultra-Sensitive Detection of Explosives like TNT and RDX
Financial Performance of Supreet Chemicals
For FY 2025, Supreet Chemicals reported robust growth with profit rising 103% to ₹51.9 crore from ₹25.6 crore in FY 2024.
Revenue during the same period increased by 51.2%, reaching ₹362.5 crore compared to ₹239.8 crore in the previous year.
Market Position and Peers
According to the DRHP, Supreet Chemicals counts Deepak Nitrite, Aarti Industries, Atul, Balaji Amines, Alkyl Amines Chemicals, Neogen Chemicals, and Rossari Biotech among its listed peers.
Lead Manager to the Supreet Chemicals IPO
IIFL Capital Services Limited is acting as the sole Book Running Lead Manager for the Supreet Chemicals IPO.
